about
Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countriesElectronic mosquito repellents for preventing mosquito bites and malaria infectionDrugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatmentLow carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysisSARS: systematic review of treatment effectsDrugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studiesDoes deworming improve growth and school performance in children?Subsidising artemisinin-based combination therapy in the private retail sectorDeworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performancePersonal protective equipment for preventing highly infectious diseases due to contact with contaminated body fluids in health care staffRapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countriesDirectly observed therapy for treating tuberculosisStrategies for expanding health insurance coverage in vulnerable populationsPrimaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionWhen trial authors write Cochrane Reviews: competing interests need to be better managedPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionRapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settingsOsmotic therapies added to antibiotics for acute bacterial meningitisPrimaquine for reducing Plasmodium falciparum transmissionGrowth monitoring and promotion (GMP) for children in low and middle income countriesIntegrated Management of Childhood Illness (IMCI) Strategy for children under five: effects on death, service utilisation and illnessDecentralising HIV treatment in lower- and middle-income countriesLarvivorous fish for preventing malaria transmissionDeworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performanceCochrane and Capacity Building in Low- and Middle-Income Countries: Where are we at?Decentralising HIV treatment delivery in middle- and low-income countriesSupplementary feeding for food insecure, vulnerable and malnourished populations - an overview of systematic reviewsSubsidising artemisinin-based combination therapies supplied to the private sector: impact on use, availability, price and market shareDeworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performanceOsmotic therapies as adjuncts to antibiotics for acute bacterial meningitisManagerial supervision to improve primary health care in low- and middle-income countriesAdjunctive steroid therapy for managing tuberculosisStrategies for integrating primary health services in low- and middle-income countries at the point of deliveryFluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Outreach strategies for expanding health insurance coverage in childrenImmunochromatography-based rapid diagnostic tests for diagnosing uncomplicated malaria in endemic countriesOutreach strategies for expanding health insurance coverage in childrenLarvivorous fish for malaria preventionArtemisinin-based combination therapy for treating uncomplicated malariaArtemisinin-based combination therapy for treating uncomplicated malaria
P50
Q21032516-62994C53-76A0-43F4-9387-107A42CD9784Q21032521-F2246C3C-3C90-42E1-BA0A-2F0D57FD04E0Q21032529-A2BE3DFF-CA8A-455A-B65B-585F6558A520Q21132002-F0AF22DC-7662-4758-A4D7-8FC2F7C2A50BQ21144696-8DADB794-4CB8-4259-A7C0-6E3B721AB6FAQ21257211-4AD2457E-2C10-4BB4-9957-FE46187B903EQ21562270-A8A52FF8-8037-401E-A229-2380CF91CFA8Q24186040-8F4A04F6-0C2B-44C5-9EE0-367F02395AF3Q24186330-EB3E15B8-E5C8-4E37-B533-649EC48E10ADQ24186944-302E52C2-6609-4EB3-8BA4-DF9B98770B50Q24187092-9F629BDC-C3AF-4D8F-857F-E35D20ED2D0BQ24187767-095CCF9B-5349-4511-A6E9-0D6B50AE0660Q24187808-23C1CA75-AC2C-489A-B672-191B668B76D1Q24188070-AE8A6C95-B1CF-4A9E-8F79-06FC3B1D194FQ24193414-D0AA0C96-CFC3-4560-A0B3-30D36333CD75Q24193716-9A04C749-C6BE-4027-A80D-F8EBC62C25ABQ24195056-CACE830E-1C1E-461E-B5A0-F7EB58553610Q24198273-7423F895-8D7B-489E-ADFC-B9F65AA6F9D0Q24200471-5CACDDF1-90FA-410A-BD35-E16DF3531103Q24200957-86DAC7B6-3059-4894-B114-B22FA2A2A782Q24201047-D1AA4871-73DF-41C2-9126-F2FDF3F9C067Q24201794-B8F66954-2E72-4A8A-BA35-4F60E41F9773Q24201852-671BCB23-68A9-4F57-83B2-F22BD9B5D256Q24202213-81DD7C88-5493-4AD6-ACEE-CC62C048509FQ24202304-7E89FAD5-69A9-46D4-9672-503C3B141794Q24202421-063F9734-8DE6-4501-B4DA-69461D1AC9C1Q24202633-837BE853-CC5E-4E82-9647-56CFC856C4FFQ24202924-3E360DC1-1ED5-4A32-B77F-8301D458F82DQ24202996-9DFB7094-910F-4D9A-9F77-210A36F65A58Q24234181-0FB2A49D-F22A-4E86-B93B-B43F23EC24DFQ24234348-CFF52C3E-F0DE-4758-9A03-84E936099746Q24234818-BBFDB333-6EFD-47C6-8D98-6CBAAB1BF14FQ24235449-684BF47D-98ED-4A8F-8341-7F0F2063D786Q24236124-1E0E3F47-1EF9-42C7-8014-2F93939206EDQ24236333-6B7BD892-2CC5-44BC-A252-F9104BD4D3E8Q24240783-6F13A82A-AD92-4103-A71C-FD37D4CCF212Q24241601-D609799F-398C-4B85-A004-3351270B7DE0Q24241615-E5B2D871-45BA-431A-8789-235F4B094728Q24241785-DC7DD179-15BD-4B2D-846B-ACEF3FED0FBDQ24242461-B8BC83B5-20EC-4CF8-B8D5-E372F3C10F33
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul Garner
@ast
Paul Garner
@en
Paul Garner
@es
Paul Garner
@fr
Paul Garner
@nl
Paul Garner
@sl
type
label
Paul Garner
@ast
Paul Garner
@en
Paul Garner
@es
Paul Garner
@fr
Paul Garner
@nl
Paul Garner
@sl
prefLabel
Paul Garner
@ast
Paul Garner
@en
Paul Garner
@es
Paul Garner
@fr
Paul Garner
@nl
Paul Garner
@sl
P106
P1153
7102107652
P2002
PaulGarnerWoof
P21
P31
P496
0000-0002-0607-6941